Download PDF
Dtsch Med Wochenschr 2008; 133(14): 720
DOI: 10.1055/s-2008-1067314
Pro & Contra | Commentary
Pneumologie
© Georg Thieme Verlag KG Stuttgart · New York

Die Therapie der pulmonal-arteriellen Hypertonie bei COPD ist sinnvoll - pro

The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - proH.-A Ghofrani1
  • 1Medizinische Klinik II/V, Universitätsklinikum Gießen und Marburg GmbH
Further Information

Publication History

Publication Date:
25 March 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

pulmonal-arterielle Hypertonie - COPD - Endothelin-Antagonisten - Prostacyclin-Analoga - Phosphodiesterase-Inhibitoren

Key words

pulmonary hypertension - COPD - endothelin antagonists - prostacyclin analogues - phosphodiesterase inhibitors

Literatur

  • 1 Alp S, Skrygan M, Schmidt W E, Bastian A. Sildenafil improves hemodynamic parameters in COPD-an investigation of six patients.  Pulm Pharmacol Ther. 2006;  19 386-390
    Google Scholar
  • 2 Ghofrani H A, Voswinckel R, Reichenberger F. et al . Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies.  Cardiovasc Res. 2006;  72 30-40
    Google Scholar
  • 3 MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two.  Am J Respir Crit Care Med. 1994;  150 1158-1168
    Google Scholar
  • 4 Santos S, Peinado V I, Ramirez J. et al . Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.  Eur Respir J. 2002;  19 632-638
    Google Scholar

Prof. Dr. Hossein-Ardeschir Ghofrani

Medizinische Klinik II/V, Universitätsklinikum Gießen und Marburg GmbH

Klinikstraße 36

35392 Gießen

Email: ardeschir.ghofrani@innere.med.uni-giessen.de

      >